APA (7th ed.) Citation

Chan, E. Y., Wong, S., Lai, F. F., Ho, T., Tong, P., Lai, W., . . . Yap, D. Y. (2023). Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis. Pediatric Nephrology, 38(12), 4001. https://doi.org/10.1007/s00467-023-06025-6

Chicago Style (17th ed.) Citation

Chan, Eugene Yu-hin, Sze-wa Wong, Fiona Fung-yee Lai, Tsz-wai Ho, Pak-chiu Tong, Wai-ming Lai, Alison Lap-tak Ma, and Desmond Yat-hin Yap. "Long-term Outcomes with Rituximab as Add-on Therapy in Severe Childhood-onset Lupus Nephritis." Pediatric Nephrology 38, no. 12 (2023): 4001. https://doi.org/10.1007/s00467-023-06025-6.

MLA (9th ed.) Citation

Chan, Eugene Yu-hin, et al. "Long-term Outcomes with Rituximab as Add-on Therapy in Severe Childhood-onset Lupus Nephritis." Pediatric Nephrology, vol. 38, no. 12, 2023, p. 4001, https://doi.org/10.1007/s00467-023-06025-6.